COVID-19: All Coverage
Researchers Optimistic About Potential COVID-19 Vaccine
While questions still remain, UNC researchers have found encouraging results from their trial of Moderna’s COVID-19 vaccine — which has a 94.5 percent efficacy rate and co-confirms similar results found in a trial of Pfizer’s vaccine. Both potential vaccines still await FDA approval.
Spike Mutation May Make COVID-19 More Susceptible to Vaccine
A common SARS-CoV-2 mutation speeds replication and transmission but may also make the virus more vaccine-susceptible than the original virus, new research shows.
How Do Masks Impact People with Hearing Impairments?
Masks provide necessary protection, but can also filter out certain sounds and block the mouth from view, exacerbating even a mild hearing loss. In this episode of “Focus Carolina,” UNC audiologist Patricia Johnson offers practical advice for communicating effectively and remaining safe.
Lab-Grown Mini-Lungs Could Enhance COVID-19 Research
UNC virologist Ralph Baric recently collaborated with Duke University researchers who developed a lab-grown living lung model that mimics the tiny air sacs of the lungs where SARS-CoV-2 infection takes place to understand how the virus affects lung cells at a molecular scale.
Study Reveals Mouth as Primary Source of COVID-19 Infection
Researchers at UNC and the National Institute of Dental and Craniofacial Research reveal coronavirus can take hold in the salivary glands where it replicates and potentially lead to prolonged disease when infected saliva is swallowed into the gastrointestinal tract or aspirated to the lungs.
A Snapshot of Reopening N.C. Schools for In-Person Learning
Researchers from the UNC Gillings School of Global Public Health are teaming up with the Frank Porter Graham Child Development Institute to determine how North Carolina schools are operating during COVID-19.
Focus Carolina: John Bamforth
John Bamforth oversees the Rapidly Emerging Antiviral Drug Discovery Initiative, or READDI, a non-profit drug research and development organization that is part of the UNC Eshelman Institute for Innovation. The mission: to find treatments for COVID-19 and to anticipate what treatments may be needed in future pandemics.
Research Leads the Way
When the pandemic began and campus pivoted to remote learning and operations, that wasn’t an option for some researchers whose experiments require highly specialized labs with samples that need to be monitored, data collected, and progress made. But UNC Research developed a plan to keep it all going.
Why Is Safe and Stable Housing Essential During COVID-19?
In this podcast, UNC city and regional planning professor Mai Nguyen discusses how her research can guide local and state governments, the private sector, and philanthropic organizations to help keep N.C. families in their homes.
WaSH Deficiencies Identified in Response to COVID-19
UNC Gillings School of Global Public Health researchers Jamie Bartram and Clarissa Brocklehurst are part of a team that created the first comprehensive review to look at how water, sanitation, and hygiene (WaSH) have impacted the global response to COVID-19